Search all medical codes

Injection, vincristine sulfate liposome, 1 mg

HCPCS code

Name of the Procedure:

Injection, Vincristine Sulfate Liposome, 1 mg
Common name(s): Vincristine injection, Oncovin liposome injection
Technical/medical term: J9371

Summary

Vincristine Sulfate Liposome injection is a procedure involving the administration of a chemotherapeutic agent in liposomal form to treat certain types of cancer.

Purpose

This procedure is utilized to treat cancers, particularly certain types of leukemia and lymphoma. The goal is to deliver chemotherapy directly into the bloodstream, which allows the drug to target cancer cells more effectively while minimizing damage to healthy cells.

Indications

  • Patients diagnosed with leukemia or lymphoma
  • Patients for whom conventional chemotherapy has not been effective
  • Patients requiring targeted delivery of vincristine sulfate to maximize effectiveness and minimize side effects

Preparation

  • Patients may need to undergo specific blood tests to determine baseline levels and kidney function.
  • Fasting for a few hours before the procedure may be required.
  • Discussing ongoing medications with healthcare providers to ensure no adverse interactions.

    Procedure Description

    1. A healthcare professional will clean the injection site, usually a vein in the arm.
    2. An IV line is inserted, through which the vincristine sulfate liposome is injected.
    3. The drug circulates through the bloodstream, targeting cancer cells.
    4. The entire process is monitored to ensure the drug is delivered safely and effectively.
  • Tools: IV catheter, vincristine sulfate liposome vial, sterile syringes
  • Typically no anesthesia or sedation is required.

Duration

The procedure typically takes around 10-30 minutes, depending on the patient's specific condition and response.

Setting

  • The procedure is often performed in an outpatient clinic, hospital, or specialized oncology treatment center.

Personnel

  • Oncologists
  • Registered nurses trained in chemotherapy administration
  • Pharmacists who prepare the chemotherapeutic agent

Risks and Complications

  • Common risks: Injection site reactions, nausea, and temporary hair loss.
  • Rare complications: Severe allergic reactions, nerve damage, and infection.
  • Management: Side effects and complications are managed through medications, monitoring, and supportive care.

Benefits

  • Effective in treating specific types of cancer, leading to potential remission.
  • The targeted delivery minimizes damage to healthy cells.
  • Improvement in symptoms may be noticed within weeks.

Recovery

  • Post-procedure care includes monitoring for adverse reactions.
  • Patients are often advised to avoid strenuous activities for the next 24 hours.
  • Routine follow-up appointments for blood tests and assessment of treatment effectiveness.

Alternatives

  • Other chemotherapy drugs or combinations.
  • Radiation therapy: useful for localized tumors.
  • Surgery: may be an option depending on the type and stage of cancer.
  • Each alternative has its benefits and limitations, which should be discussed with the healthcare provider.

Patient Experience

  • Patients may feel a brief sting or pinch at the injection site.
  • Since it’s a quick procedure, discomfort is minimal.
  • Pain management: Over-the-counter pain relievers can be used if needed.
  • Comfort measures: Patients are encouraged to rest and maintain hydration post-procedure.

Medical Policies and Guidelines for Injection, vincristine sulfate liposome, 1 mg

Related policies from health plans

Similar Codes